Unique ID issued by UMIN | UMIN000050130 |
---|---|
Receipt number | R000057095 |
Scientific Title | Assessment of the effectiveness of 2GA16-containing formulation for atopic dermatitis |
Date of disclosure of the study information | 2023/02/01 |
Last modified on | 2023/11/29 12:19:31 |
Assessment of the safety and efficacy of 2GA16-containing cream in patients with atopic dermatitis
Assessment of the safety and efficacy of 2GA16-containing cream in patients with atopic dermatitis
Assessment of the effectiveness of 2GA16-containing formulation for atopic dermatitis
Assessment of the effectiveness of 2GA16-containing formulation for atopic dermatitis
Japan |
Atopic dermatitis
Dermatology |
Others
NO
To evaluate the efficacy and safety of 2GA16-containing moisturizer in the standard treatment of atopic dermatitis.
Safety,Efficacy
Observation of skin findings and confirmation of adverse events by a dermatologist
Transepidermal water loss
Stratum corneum water content
Stratum corneum analysis
Image analysis
Patient questionnaires
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine | Other |
Left-right comparison study (face)
A group
Left side: test cream
Right side: 0.3% heparinoid-containing cream
Each creams are applied twice daily for 11 weeks.
Left-right comparison study (face)
B group
Left side: 0.3% heparinoid-containing cream
Right side: test cream
Each creams are applied twice daily for 11 weeks.
20 | years-old | <= |
60 | years-old | > |
Female
1) Japanese females between 20 and 59 years old with atopic dermatitis
2) Subjects with mild atopic dermatitis symptoms on the left and right sides of the face
3) Subjects who are currently undergoing treatment with topical agents, or who have had treatment after becoming an adult
1) Those with atopic dermatitis who do not meet the selection criteria
2) Those who are taking systemic administration (oral or intravenous injection) of steroids, JAK inhibitors, biologics or immunosuppressant
3) Those who regularly use anti-inflammatory medications or antiallergic medications
4) Those who are undergoing PUVA therapy
5) Those who have undergone aesthetic medicine or special skin care treatments (peeling, hair removal treatment, etc.) within 4 weeks prior to the 0w test date, or those who plan to receive them during the test period.
6) Subjects who have been exposed to ultraviolet rays beyond their daily lives, such as working outdoors for long periods of time, exercising, swimming at the beach, or leisure activities within 4 weeks prior to the 0w test date, and those who have such a plan during the exam period
7) Those who work night shift or day and night shift
8) Those who are receiving treatment other than atopic dermatitis at a medical institution at the time of obtaining consent
9) Those who are a history of alcohol or drug dependence
10) Those who are likely to develop allergies to cosmetics and food (including those who have experienced skin abnormalities such as rashes due to cosmetics within the past year)
11) Those who have other serious underlying diseases
12) Those who are currently participating in other clinical trials, or those who have participated in clinical trials within the past 2 months
13) Women who are pregnant, planning to become pregnant, or breastfeeding
14) Those who have difficulty coming to the hospital on the specified date
15) In addition, those who are judged to be inappropriate for participation in this study by the principal investigator
30
1st name | Koichi |
Middle name | |
Last name | Nakaoji |
Pias Corporation
Central R&D Laboratory
6512241
1-3-1, Murotani, Nishi-ku, Kobe, Hyogo, Japan
078-992-6591
knakaoji@pias.co.jp
1st name | Shunya |
Middle name | |
Last name | Sahara |
Pias Corporation
Central R&D Laboratory
6512241
1-3-1, Murotani, Nishi-ku, Kobe, Hyogo, Japan
078-992-6591
ssahara@pias.co.jp
Pias Corporation
None
Self funding
The Ethics Committee of Shibukawa Central Hospital, Medical Corporation Kikuei-kai
508-1, Ishihara, Shibukawa, Gunma, Japan
0279-26-9102
aoyama@oms-laboratory.co.jp
NO
2023 | Year | 02 | Month | 01 | Day |
Unpublished
24
Completed
2023 | Year | 01 | Month | 13 | Day |
2023 | Year | 01 | Month | 16 | Day |
2023 | Year | 02 | Month | 06 | Day |
2023 | Year | 04 | Month | 27 | Day |
2023 | Year | 01 | Month | 25 | Day |
2023 | Year | 11 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057095
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |